Frontlight ResearchEarly access
CompletedPhase 1
Evaluation of the Role of Acetyl Cysteine in Ventilator Associated Pneumonia by Carbapenem Resistance Klebsiella
Key facts
- Who runs it
- Tanta University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 1
- People taking part
- 70 people enrolled
- Started
- 30 Oct 2023
- Ended
- 30 Oct 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- acetyl cysteine 600 mg
- antibiotics and saline.
- Record updated
- 31 July 2025
Who can take part
- Age
- 21 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patients who are mechanically ventilated
- Age from 21 to 65
- Both sexes
Who cannot take part
- Patients on steroid or immunosuppressive drugs
- Patient guardians who refuse the consent • Hypersensitivity to acetyl Cysteine
- Extrapulmonary infection
- Cardiac patient with chronic heart failure
- Patient with lung diseases (tumors, tuberculosis, ,Chronic Obstructive Pulmonary Disease, Bronchiectasis and lung fibrosis)
- Severe immunosuppression (total leucocyte < 1000 mm3 or neutrophil < 500 cell/mm3
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of the study is to evaluate the role of addition of Acetyl cysteine in the management of VAP induced by carbapenem resistant klebsiella. The primary outcome indicator is the change in modified clinical pulmonary infection score. The secondary outcome indicator is duration of mechanical ventilation.
The 2 groups in the trial
- acetyl cysteine 600 mgTreatment being tested
patients received acetyl cysteine 600 mg/ 12h IV in addition to antibiotics
- antibiotics and salineTreatment being tested
patients received only antibiotics and saline.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of the Role of Acetyl Cysteine in The Treatment of Ventilator Associated Pneumonia Induced by Carbapenem Resistance Klebsiella
- Record updated
- 31 July 2025